Hcq

Brazilian President Jair Bolsonaro has gone all in on hydroxychloroquine to help his novel coronavirus-ravaged country beat COVID-19.

Why India needs to reassess use of HCQ for COVID-19 treatment

India has been using hydroxychloroquine, commonly known as HCQ, for treatment of COVID-19 patients and as prophylactic in high-risk groups such as healthcare and other frontline workers.

Hydroxychloroquine should be avoided in severe cases: Health Ministry

Hydroxychloroquine has demonstrated in-vitro activity against SARS-CoV2 and was shown to be clinically beneficial in several small single-centre studies though with significant limitations, it stated.

Coronavirus crisis | India could lift export ban on HCQ: Report

HCQ, which is currently used to treat lupus and rheumatoid arthritis, is being touted as a possible treatment for COVID-19, the disease caused by the novel coronavirus.

Coronavirus pandemic | Experts seek more clinical evidence as India expands prophylactic use of HCQ

The National Task force for COVID-19, constituted by ICMR, has reviewed the use of HCQ for prophylaxis of SARS-CoV-2 infections for high-risk population based on emerging evidence on its safety and efficacy.

Coronavirus crisis | HIV drug may replace HCQ in ICMR’s revised COVID-19 treatment protocol: Report

According to a report, ICMR is also planning to conduct a trial on HCQ’s effectiveness against COVID-19.

Hydroxychloroquine to be given to health workers treating COVID-19 patients

State health secretary Pradeep Vyas in a recent circular said the medicine will be given to doctors, nurses and medical staff involved in the treatment of COVID-19 patients and suspects

Big Story | Does India have enough hydroxychloroquine supplies?

In this edition of Big Story, Moneycontrol's Sakshi Batra finds out whether India has enough supply of hydroxychloroquine to meet its own domestic needs?

Cadila Healthcare Q2 profit seen up 31% on US formulations

Opinion is mixed on the amount of growth in US markets as some analysts expect 20-25 percent growth due to arthritis drug HCQs price hikes (Hydroxychloroquine) while others expect constant currency growth of around 13-15 percent due to erosion in other products.